Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.
Lam MK, Sen H, Tandjung K, Löwik MM, Basalus MW, Mewes JC, Stoel MG, van Houwelingen KG, Linssen GC, Ijzerman MJ, Doggen CJ, von Birgelen C. Lam MK, et al. Among authors: tandjung k. Catheter Cardiovasc Interv. 2015 Mar;85(4):524-31. doi: 10.1002/ccd.25518. Epub 2014 May 8. Catheter Cardiovasc Interv. 2015. PMID: 24753036 Clinical Trial.
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents.
Tandjung K, Basalus MW, Muurman E, Louwerenburg HW, van Houwelingen KG, Stoel MG, de Man FH, Jansen H, Huisman J, Linssen GC, Droste HT, Nienhuis MB, von Birgelen C. Tandjung K, et al. Catheter Cardiovasc Interv. 2012 Oct 1;80(4):524-30. doi: 10.1002/ccd.23334. Epub 2011 Dec 2. Catheter Cardiovasc Interv. 2012. PMID: 22109857
A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, Louwerenburg JH, Linssen GC, Saïd SA, Kleijne MA, Sen H, Löwik MM, van der Palen J, Verhorst PM, de Man FH. von Birgelen C, et al. Among authors: tandjung k. J Am Coll Cardiol. 2012 Apr 10;59(15):1350-61. doi: 10.1016/j.jacc.2012.01.008. Epub 2012 Feb 15. J Am Coll Cardiol. 2012. PMID: 22341737 Free article. Clinical Trial.
DUrable polymer-based sTent CHallenge of Promus ElemEnt versus ReSolute integrity (DUTCH PEERS): rationale and study design of a randomized multicenter trial in a Dutch all-comers population.
Tandjung K, Basalus MW, Sen H, Jessurun GA, Danse PW, Stoel M, Linssen GC, Derks A, van Loenhout TT, Nienhuis MB, Hautvast RW, von Birgelen C. Tandjung K, et al. Am Heart J. 2012 Apr;163(4):557-62. doi: 10.1016/j.ahj.2012.02.001. Am Heart J. 2012. PMID: 22520520 Clinical Trial.
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents.
Sen H, Tandjung K, Basalus MW, Löwik MM, van Houwelingen GK, Stoel MG, Louwerenburg HW, de Man FH, Linssen GC, Nijhuis R, Nienhuis MB, Verhorst PM, van der Palen J, von Birgelen C. Sen H, et al. Among authors: tandjung k. EuroIntervention. 2012 Oct;8(6):664-71. doi: 10.4244/EIJV8I6A104. EuroIntervention. 2012. PMID: 22581199 Free article. Clinical Trial.
Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial).
Tandjung K, van Houwelingen KG, Jansen H, Basalus MW, Sen H, Löwik MM, Stoel MG, Louwerenburg JH, de Man FH, Linssen GC, Nijhuis R, Nienhuis MB, van der Palen J, Stolk RP, von Birgelen C. Tandjung K, et al. Am J Cardiol. 2012 Dec 1;110(11):1561-7. doi: 10.1016/j.amjcard.2012.07.019. Epub 2012 Aug 31. Am J Cardiol. 2012. PMID: 22939581 Clinical Trial.
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial.
Tandjung K, Basalus MW, Sen H, Stoel MG, van Houwelingen KG, Louwerenburg JH, de Man FH, Linssen GC, Saïd SA, Kleijne MA, van der Palen J, von Birgelen C. Tandjung K, et al. Catheter Cardiovasc Interv. 2013 Sep 1;82(3):396-405. doi: 10.1002/ccd.24848. Epub 2013 Mar 8. Catheter Cardiovasc Interv. 2013. PMID: 23359390 Free article. Clinical Trial.
33 results